{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T23:03:41Z","timestamp":1794351821912,"version":"4.9.0"},"reference-count":94,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"Supplement 1","license":[{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/ http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2019,1]]},"abstract":"<jats:p>In most cases of suspected endometrial neoplasia tumor origin can be correctly assigned according to a combination of clinical, radiologic, and pathologic features, even when the latter are based upon the examination of relatively small biopsy samples. However there are well-recognized exceptions to this rule which continue to create diagnostic difficulty, and sometimes difficulties persist even after the detailed examination of resection specimens. Among the most common problems encountered in practice are the distinction of primary endometrial and primary endocervical adenocarcinomas, and the determination of tumor origin when there is synchronous, multifocal involvement of gynecologic tract sites, for example the endometrium and the ovary. However, accurate diagnosis in these cases is important because this has significant staging, management and prognostic implications. In this review we discuss the value and limitations of key morphologic, immunophenotypic and molecular findings in these diagnostic scenarios.<\/jats:p>","DOI":"10.1097\/pgp.0000000000000553","type":"journal-article","created":{"date-parts":[[2018,12,14]],"date-time":"2018-12-14T21:58:00Z","timestamp":1544824680000},"page":"S75-S92","source":"Crossref","is-referenced-by-count":69,"title":["Guidelines to Aid in the Distinction of Endometrial and Endocervical Carcinomas, and the Distinction of Independent Primary Carcinomas of the Endometrium and Adnexa From Metastatic Spread Between These and Other Sites"],"prefix":"10.1097","volume":"38","author":[{"given":"Colin J.R.","family":"Stewart","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher P.","family":"Crum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W. Glenn","family":"McCluggage","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kay J.","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joanne K.","family":"Rutgers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Esther","family":"Oliva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anais","family":"Malpica","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vinita","family":"Parkash","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xavier","family":"Matias-Guiu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brigitte M.","family":"Ronnett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20230824","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1097\/PAS.0b013e3181971fdd","article-title":"Endocervical adenocarcinoma with prominent endometrial or endomyometrial involvement simulating primary endometrial carcinomas: utility of HPV DNA detection and immunohistochemical expression of p16 and hormone receptors to confirm the cervical origin of the corpus tumor","volume":"33","author":"Yemelyanova","year":"2009","journal-title":"Am J Surg Pathol"},{"key":"R2-20230824","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1097\/00000478-200208000-00004","article-title":"Hormone receptor immunohistochemistry and human papillomavirus in situ hybridization are useful for distinguishing endocervical and endometrial adenocarcinomas","volume":"26","author":"Staebler","year":"2002","journal-title":"Am J Surg Pathol"},{"key":"R3-20230824","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1097\/00000478-200402000-00002","article-title":"Distinction of endocervical and endometrial adenocarcinomas: immunohistochemical p16 expression correlated with human papillomavirus (HPV) DNA detection","volume":"28","author":"Ansari-Lari","year":"2004","journal-title":"Am J Surg Pathol"},{"key":"R4-20230824","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1097\/PAS.0b013e3181e3291e","article-title":"A panel of 3 markers including p16, ProExC, or HPV ISH is optimal for distinguishing between primary endometrial and endocervical adenocarcinomas","volume":"34","author":"Kong","year":"2010","journal-title":"Am J Surg Pathol"},{"key":"R5-20230824","doi-asserted-by":"crossref","first-page":"1504","DOI":"10.1097\/PAS.0b013e3181ac35f5","article-title":"Utility of p16 expression for distinction of uterine serous carcinomas from endometrial endometrioid and endocervical adenocarcinomas: immunohistochemical analysis of 201 cases","volume":"33","author":"Yemelyanova","year":"2009","journal-title":"Am J Surg Pathol"},{"key":"R6-20230824","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1111\/his.12895","article-title":"Hormone receptor-negative, thyroid transcription factor 1-positive uterine and ovarian adenocarcinomas: report of a series of mesonephric-like adenocarcinomas","volume":"68","author":"McFarland","year":"2016","journal-title":"Histopathology"},{"key":"R7-20230824","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1097\/00004347-200201000-00002","article-title":"Distinction between endometrial and endocervical adenocarcinoma: an immunohistochemical study","volume":"21","author":"Castrillon","year":"2002","journal-title":"Int J Gynecol Pathol"},{"key":"R8-20230824","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1097\/00004347-200201000-00003","article-title":"A panel of immunohistochemical stains, including carcinoembryonic antigen, vimentin, and estrogen receptor, aids the distinction between primary endometrial and endocervical adenocarcinomas","volume":"21","author":"McCluggage","year":"2002","journal-title":"Int J Gynecol Pathol"},{"key":"R9-20230824","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1097\/00004347-200207000-00003","article-title":"Immunohistochemical staining in the distinction between primary endometrial and endocervical adenocarcinomas: another viewpoint","volume":"21","author":"Kamoi","year":"2002","journal-title":"Int J Gynecol Pathol"},{"key":"R10-20230824","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1046\/j.1365-2559.2003.01684.x","article-title":"CD10 and calretinin staining of endocervical glandular lesions, endocervical stroma and endometrioid adenocarcinomas of the uterine corpus: CD10 positivity is characteristic of, but not specific for, mesonephric lesions and is not specific for endometrial stroma","volume":"43","author":"McCluggage","year":"2003","journal-title":"Histopathology"},{"key":"R11-20230824","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1097\/PGP.0b013e318223118a","article-title":"P16INK4a expression in undifferentiated carcinoma of the uterus does not exclude its endometrial origin","volume":"31","author":"Saad","year":"2012","journal-title":"Int J Gynecol Pathol"},{"key":"R12-20230824","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1097\/01.pgp.0000235065.31301.3e","article-title":"Immunohistochemical overexpression of p16 and p53 in uterine serous carcinoma and ovarian high-grade serous carcinoma","volume":"26","author":"Chiesa-Vottero","year":"2007","journal-title":"Int J Gynecol Pathol"},{"key":"R13-20230824","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1111\/j.1365-2559.2011.03907.x","article-title":"Patterns of p53 immunoreactivity in endometrial carcinomas: \u201call or nothing\u201d staining is of importance","volume":"59","author":"McCluggage","year":"2011","journal-title":"Histopathology"},{"key":"R14-20230824","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1002\/path.2744","article-title":"The biological and clinical value of p53 expression in pelvic high-grade serous carcinomas","volume":"222","author":"Kobel","year":"2010","journal-title":"J Pathol"},{"key":"R15-20230824","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1097\/PAP.0b013e3181b507c6","article-title":"The expression and diagnostic utility of p63 in the female genital tract","volume":"16","author":"Houghton","year":"2009","journal-title":"Adv Anat Pathol"},{"key":"R16-20230824","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1007\/978-1-4939-2013-6_16","article-title":"Diagnosis of HPV-negative, gastric-type adenocarcinoma of the endocervix","volume":"1249","author":"Pirog","year":"2015","journal-title":"Methods Mol Biol"},{"key":"R17-20230824","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1097\/PAS.0000000000000578","article-title":"A detailed immunohistochemical analysis of a large series of cervical and vaginal gastric-type adenocarcinomas","volume":"40","author":"Carlton","year":"2016","journal-title":"Am J Surg Pathol"},{"key":"R18-20230824","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1097\/PAS.0b013e31824a72c6","article-title":"Mesonephric adenocarcinomas of the uterine cervix and corpus: HPV-negative neoplasms that are commonly PAX8, CA125, and HMGA2 positive and that may be immunoreactive with TTF1 and hepatocyte nuclear factor 1-beta","volume":"36","author":"Kenny","year":"2012","journal-title":"Am J Surg Pathol"},{"key":"R19-20230824","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1097\/PAS.0b013e31821534b9","article-title":"Unusual endocervical adenocarcinomas: an immunohistochemical analysis with molecular detection of human papillomavirus","volume":"35","author":"Park","year":"2011","journal-title":"Am J Surg Pathol"},{"key":"R20-20230824","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1097\/PAS.0000000000000471","article-title":"GATA3 is a sensitive and specific marker of benign and malignant mesonephric lesions in the lower female genital tract","volume":"39","author":"Howitt","year":"2015","journal-title":"Am J Surg Pathol"},{"key":"R21-20230824","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1097\/PGP.0000000000000167","article-title":"Differential expression patterns of GATA3 in uterine mesonephric and nonmesonephric lesions","volume":"34","author":"Roma","year":"2015","journal-title":"Int J Gynecol Pathol"},{"key":"R22-20230824","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1309\/AJCP5UAFMSA9ZQBZ","article-title":"Immunohistochemical evaluation of GATA3 expression in tumors and normal tissues. A useful immunomarker for breast and urothelial carcinomas","volume":"138","author":"Liu","year":"2012","journal-title":"Am J Clin Pathol"},{"key":"R23-20230824","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1097\/PAS.0b013e3182a0218f","article-title":"GATA3\u2014a multispecific but potentially useful marker in surgical pathology\u2014a systematic analysis of 2500 epithelial and non-epithelial tumors","volume":"38","author":"Miettinen","year":"2014","journal-title":"Am J Surg Pathol"},{"key":"R24-20230824","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1309\/AJCP8H2VBDSCIOBF","article-title":"Semiquantitative GATA-3 immunoreactivity in breast, bladder, gynecologic tract, and other cytokeratin 7\u2014positive carcinomas","volume":"142","author":"Clark","year":"2014","journal-title":"Am J Clin Pathol"},{"key":"R25-20230824","doi-asserted-by":"crossref","first-page":"543.e1","DOI":"10.1016\/j.ajog.2008.04.043","article-title":"GATA3 expression in estrogen receptor \u03b1-negative endometrial carcinomas identifies aggressive tumors with high proliferation and poor patient survival","volume":"199","author":"Engelsen","year":"2008","journal-title":"Am J Obstet Gynecol"},{"key":"R26-20230824","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1111\/j.1365-2559.2009.03367.x","article-title":"Synchronous tumours of the female genital tract","volume":"56","author":"Singh","year":"2010","journal-title":"Histopathology"},{"key":"R27-20230824","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1097\/PAS.0b013e3181d6b8fd","article-title":"Metastatic carcinomas in the cervix mimicking primary cervical adenocarcinoma and adenocarcinoma in situ: report of a series of cases","volume":"34","author":"McCluggage","year":"2010","journal-title":"Am J Surg Pathol"},{"key":"R28-20230824","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1097\/PGP.0b013e318217137e","article-title":"Ovarian low-grade serous carcinoma involving the cervix mimicking a cervical primary","volume":"30","author":"Malpica","year":"2011","journal-title":"Int J Gynecol Pathol"},{"key":"R29-20230824","doi-asserted-by":"crossref","first-page":"191","DOI":"10.3802\/jgo.2010.21.3.191","article-title":"Uterine metastases in ovarian carcinoma: frequency and survival in women who underwent hysterectomy","volume":"21","author":"Menczer","year":"2010","journal-title":"J Gynecol Oncol"},{"key":"R30-20230824","doi-asserted-by":"crossref","first-page":"E106","DOI":"10.1111\/j.1365-2559.2012.04194.x","article-title":"Fallopian tube metastases of non-gynaecological origin: a series of 20 cases emphasizing patterns of involvement including intra-epithelial spread","volume":"60","author":"Stewart","year":"2012","journal-title":"Histopathology"},{"key":"R31-20230824","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1097\/PAS.0000000000000293","article-title":"Nongynecologic metastases to fallopian tube mucosa: a potential mimic of tubal high-grade serous carcinoma and benign tubal mucinous metaplasia or nonmucinous hyperplasia","volume":"39","author":"Rabban","year":"2015","journal-title":"Am J Surg Pathol"},{"key":"R32-20230824","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1097\/PGP.0000000000000206","article-title":"Secondary involvement of the adnexa and uterine corpus by carcinomas of the uterine cervix: a detailed morphologic description","volume":"34","author":"Reyes","year":"2015","journal-title":"Int J Gynecol Pathol"},{"key":"R33-20230824","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1097\/PAS.0000000000000757","article-title":"Uterine serous carcinomas frequently metastasize to the fallopian tube and can mimic serous tubal intraepithelial carcinoma","volume":"41","author":"Kommoss","year":"2017","journal-title":"Am J Surg Pathol"},{"key":"R34-20230824","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1016\/j.ygyno.2015.07.012","article-title":"Ovarian involvement in endometrioid adenocarcinoma of uterus","volume":"138","author":"Lin","year":"2015","journal-title":"Gynecol Oncol"},{"key":"R35-20230824","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1097\/IGC.0000000000000073","article-title":"Prognostic factors in women with synchronous endometrial and ovarian cancers","volume":"24","author":"Song","year":"2014","journal-title":"Int J Gynecol Cancer"},{"key":"R36-20230824","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1097\/IGC.0b013e318219711f","article-title":"Risk factors for developing multiple malignancies in patients with endometrial cancer","volume":"21","author":"Uccella","year":"2011","journal-title":"Int J Gynecol Cancer"},{"key":"R37-20230824","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.ygyno.2015.02.028","article-title":"Clinical and pathological characterization of endometrial cancer in young women: identification of a cohort without classical risk factors","volume":"138","author":"Burleigh","year":"2015","journal-title":"Gynecol Oncol"},{"key":"R38-20230824","first-page":"1484","article-title":"Synchronous primary cancers of the endometrium and ovary: a single institution review of 84 cases","volume":"35","author":"Soliman","year":"2004","journal-title":"Hum Pathol"},{"key":"R39-20230824","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1097\/IGC.0000000000000019","article-title":"Synchronous ovarian and endometrial cancer\u2014an international multicenter case-control study","volume":"24","author":"Heitz","year":"2014","journal-title":"Int J Gynecol Cancer"},{"key":"R40-20230824","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1111\/j.1525-1438.2007.00975.x","article-title":"Synchronous primary cancers of the endometrium and ovary","volume":"18","author":"Chiang","year":"2008","journal-title":"Int J Gynecol Cancer"},{"key":"R41-20230824","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1006\/gyno.2001.6400","article-title":"Simultaneously detected endometrial and ovarian carcinomas - a prospective clinicopathologic study of 74 cases: a gynecologic oncology group study","volume":"83","author":"Zaino","year":"2001","journal-title":"Gynecol Oncol"},{"key":"R42-20230824","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1097\/PGP.0b013e31823ef951","article-title":"Why do women with double primary carcinoma of the endometrium and ovary have a favorable prognosis?","volume":"31","author":"van Altena","year":"2012","journal-title":"Int J Gynecol Pathol"},{"key":"R43-20230824","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1097\/IGC.0000000000000600","article-title":"Synchronous primary cancers of the endometrium and ovary with the same histopathologic type versus endometrial cancer with ovarian metastasis: a single institution review of 72 cases","volume":"26","author":"Bese","year":"2016","journal-title":"Int J Gynecol Cancer"},{"key":"R44-20230824","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1055\/s-0032-1315206","article-title":"Endometrial cancer: comparison of patients with synchronous primary carcinoma of the endometrium and ovary vs. endometrial carcinoma with ovarian metastases","volume":"72","author":"Juhasz-Boss","year":"2012","journal-title":"Geburtshilfe Frauenheilkd"},{"key":"R45-20230824","doi-asserted-by":"crossref","first-page":"239","DOI":"10.3802\/jgo.2011.22.4.239","article-title":"Survival outcome of women with synchronous cancers of endometrium and ovary: a 10 year retrospective cohort study","volume":"22","author":"Lim","year":"2011","journal-title":"J Gynecol Oncol"},{"key":"R46-20230824","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.1111\/jog.12826","article-title":"Clinicopathologic and survival analyses of synchronous primary endometrial and epithelial ovarian cancers","volume":"41","author":"Sozen","year":"2015","journal-title":"J Obstet Gynaecol Res"},{"key":"R47-20230824","doi-asserted-by":"crossref","first-page":"441","DOI":"10.17772\/gp\/1750","article-title":"Synchronous tumors of the female genital tract: a 20-year experience in a single center","volume":"85","author":"Saatli","year":"2014","journal-title":"Ginekol Pol"},{"key":"R48-20230824","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.ejogrb.2006.09.010","article-title":"Clinical analysis of synchronous primary neoplasms of the female genital tract","volume":"136","author":"Tong","year":"2008","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"R49-20230824","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1097\/AOG.0b013e31819c7bdf","article-title":"Synchronous primary ovarian and endometrial cancers: a population-based assessment of survival","volume":"113","author":"Williams","year":"2009","journal-title":"Obstet Gynecol"},{"key":"R50-20230824","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1097\/IGC.0000000000000377","article-title":"Clinicopathologic analysis with immunohistochemistry for DNA mismatch repair protein expression in synchronous primary endometrial and ovarian cancers","volume":"25","author":"Kobayashi","year":"2015","journal-title":"Int J Gynecol Cancer"},{"key":"R51-20230824","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.path.2016.01.004","article-title":"Lynch syndrome: female genital tract cancer diagnosis and screening","volume":"9","author":"Mills","year":"2016","journal-title":"Surgl Pathol Clin"},{"key":"R52-20230824","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1002\/1097-0142(19820701)50:1<163::AID-CNCR2820500131>3.0.CO;2-K","article-title":"Simultaneous presentation of carcinoma involving the ovary and the uterine corpus","volume":"50","author":"Eifel","year":"1982","journal-title":"Cancer"},{"key":"R53-20230824","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1053\/j.semdp.2014.03.006","article-title":"Use of immunohistochemistry in the diagnosis of miscellaneous and metastatic tumors of the uterine corpus and cervix","volume":"31","author":"Euscher","year":"2014","journal-title":"Semin Diagn Pathol"},{"key":"R54-20230824","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1097\/01.pas.0000209839.00467.05","article-title":"Endometrioid carcinoma simultaneously involving the uterus and the fallopian tube: a clinicopathologic study of 13 cases","volume":"30","author":"Culton","year":"2006","journal-title":"Am J Surg Pathol"},{"key":"R55-20230824","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1007\/s10147-009-0935-y","article-title":"Ovarian cancer in endometriosis: molecular biology, pathology, and clinical management","volume":"14","author":"Mandai","year":"2009","journal-title":"Int J Clin Oncol"},{"key":"R56-20230824","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1097\/00019606-200106000-00008","article-title":"Beta-catenin expression pattern, beta-catenin gene mutations, and microsatellite instability in endometrioid ovarian carcinomas and synchronous endometrial carcinomas","volume":"10","author":"Moreno-Bueno","year":"2001","journal-title":"Diagn Mol Pathol"},{"key":"R57-20230824","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1016\/j.humpath.2005.03.005","article-title":"Synchronous endometrioid carcinomas of the uterine corpus and ovary: alterations in the \u03b2-catenin (CTNNB1) pathway are associated with independent primary tumors and favorable prognosis","volume":"36","author":"Irving","year":"2005","journal-title":"Hum Pathol"},{"key":"R58-20230824","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1097\/PGP.0b013e31829040b5","article-title":"Differential vimentin expression in ovarian and uterine corpus endometrioid adenocarcinomas: diagnostic utility in distinguishing double primaries from metastatic tumors","volume":"33","author":"Desouki","year":"2014","journal-title":"Int J Gynecol Pathol"},{"key":"R59-20230824","doi-asserted-by":"crossref","first-page":"1484","DOI":"10.1016\/j.humpath.2004.08.011","article-title":"Frequent microsatellite instability in synchronous ovarian and endometrial adenocarcinoma and its usefulness for differential diagnosis","volume":"35","author":"Kaneki","year":"2004","journal-title":"Hum Pathol"},{"key":"R60-20230824","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1097\/00019606-200306000-00002","article-title":"PTEN as a molecular marker to distinguish metastatic from primary synchronous endometrioid carcinomas of the ovary and uterus","volume":"12","author":"Ricci","year":"2003","journal-title":"Diagn Mol Pathol"},{"key":"R61-20230824","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1053\/hupa.2002.124118","article-title":"Genetics of synchronous uterine and ovarian endometrioid carcinoma: combined analyses of loss of heterozygosity, PTEN mutation, and microsatellite instability","volume":"33","author":"Fujii","year":"2002","journal-title":"Hum Pathol"},{"key":"R62-20230824","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1093\/ajcp\/105.3.350","article-title":"Application of clonal analysis. Differential diagnosis for synchronous primary ovarian and endometrial cancers and metastatic cancer","volume":"105","author":"Fujita","year":"1996","journal-title":"Am J Clin Pathol"},{"key":"R63-20230824","doi-asserted-by":"crossref","first-page":"2455","DOI":"10.1002\/1097-0142(19911201)68:11<2455::AID-CNCR2820681122>3.0.CO;2-Q","article-title":"Simultaneous carcinoma involving the endometrium and the ovary. A cliniciopathologic, immunohistochemical, and DNA flow cytometric study of 18 cases","volume":"68","author":"Prat","year":"1991","journal-title":"Cancer"},{"key":"R64-20230824","doi-asserted-by":"crossref","first-page":"1412","DOI":"10.1038\/modpathol.2014.39","article-title":"Mitochondrial DNA genotyping efficiently reveals clonality of synchronous endometrial and ovarian cancers","volume":"27","author":"Guerra","year":"2014","journal-title":"Mod Pathol"},{"key":"R65-20230824","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1007\/s10552-017-0855-5","article-title":"Synchronous endometrial and ovarian carcinomas: predictors of risk and associations with survival and tumor expression profiles","volume":"28","author":"Kelemen","year":"2017","journal-title":"Cancer Causes Control"},{"key":"R66-20230824","doi-asserted-by":"crossref","first-page":"5840","DOI":"10.1158\/1078-0432.CCR-08-0373","article-title":"Predicting clinical outcome in patients diagnosed with synchronous ovarian and endometrial cancer","volume":"14","author":"Ramus","year":"2008","journal-title":"Clin Cancer Res"},{"key":"R67-20230824","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1093\/jnci\/djh272","article-title":"A molecular genetic and statistical approach for the diagnosis of dual-site cancers","volume":"96","author":"Brinkmann","year":"2004","journal-title":"J Natl Cancer Inst"},{"key":"R68-20230824","doi-asserted-by":"crossref","first-page":"djv428","DOI":"10.1093\/jnci\/djv428","article-title":"Synchronous endometrial and ovarian carcinomas: evidence of clonality","volume":"108","author":"Anglesio","year":"2016","journal-title":"J Natl Cancer Inst"},{"key":"R69-20230824","doi-asserted-by":"crossref","first-page":"djv427","DOI":"10.1093\/jnci\/djv427","article-title":"Massively parallel sequencing-based clonality analysis of synchronous endometrioid endometrial and ovarian carcinomas","volume":"108","author":"Schultheis","year":"2016","journal-title":"J Natl Cancer Inst"},{"key":"R70-20230824","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.ygyno.2016.07.114","article-title":"Implication of genomic characterization in synchronous endometrial and ovarian cancers of endometrioid histology","volume":"143","author":"Chao","year":"2016","journal-title":"Gynecol Oncol"},{"key":"R71-20230824","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1111\/j.1525-1438.2006.00293.x","article-title":"Discordant genetic changes in ovarian and endometrial endometrioid carcinomas: a potential pitfall in molecular diagnosis","volume":"16","author":"Chang","year":"2006","journal-title":"Int J Gynecol Cancer"},{"key":"R72-20230824","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1097\/00004347-200207000-00001","article-title":"Clonality analysis in synchronous or metachronous tumors of the female genital tract","volume":"21","author":"Matias-Guiu","year":"2002","journal-title":"Int J Gynecol Pathol"},{"key":"R73-20230824","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1016\/j.anndiagpath.2012.01.007","article-title":"Clonality in gynecologic neoplasms: is it time to reevaluate clonality studies in gynecologic neoplasms? Is it possible to confirm multicentricity with clonality studies?","volume":"16","author":"Silva","year":"2012","journal-title":"Ann Diagn Pathol"},{"key":"R74-20230824","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1053\/hupa.2002.124717","article-title":"Clonality analysis in synchronous tumors of the female genital tract","volume":"33","author":"Prat","year":"2002","journal-title":"Hum Pathol"},{"key":"R75-20230824","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1097\/01.pgp.0000179614.47838.82","article-title":"Transtubal spread of serous adenocarcinoma of the endometrium: an underrecognized mechanism of metastasis","volume":"25","author":"Snyder","year":"2006","journal-title":"Int J Gynecol Pathol"},{"key":"R76-20230824","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1097\/PGP.0b013e3181934390","article-title":"Coexisting intraepithelial serous carcinomas of the endometrium and fallopian tube: frequency and potential significance","volume":"28","author":"Jarboe","year":"2009","journal-title":"Int J Gynecol Pathol"},{"key":"R77-20230824","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1097\/PGP.0b013e3181c1158e","article-title":"Coexisting serous carcinoma of the endometrium and the fallopian tube","volume":"29","author":"Stewart","year":"2010","journal-title":"Int J Gynecol Pathol"},{"key":"R78-20230824","first-page":"31","article-title":"Transtubal spread of endometrial carcinoma: correlation of intra-luminal tumour cells with tumour grade, peritoneal fluid cytology, and extra-uterine metastasis","volume":"62","author":"Stewart","year":"2013","journal-title":"Pathology"},{"key":"R79-20230824","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1016\/j.humpath.2011.03.003","article-title":"Molecular pathogenesis and extraovarian origin of epithelial ovarian cancer- shifting the paradigm","volume":"42","author":"Kurman","year":"2011","journal-title":"Hum Pathol"},{"key":"R80-20230824","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1097\/PAT.0000000000000291","article-title":"The secondary M\u00fcllerian system, field effect, BRCA, and tubal fimbria: our evolving understanding of the origin of tubo-ovarian high-grade serous carcinoma and why assignment of primary site matters","volume":"47","author":"Singh","year":"2015","journal-title":"Pathology"},{"key":"R81-20230824","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1038\/modpathol.2015.77","article-title":"Data set for reporting of ovary, fallopian tube and primary peritoneal carcinoma: recommendations from the International Collaboration on Cancer Reporting (ICCR)","volume":"28","author":"McCluggage","year":"2015","journal-title":"Mod Pathol"},{"key":"R82-20230824","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1097\/01.pas.0000180854.28831.77","article-title":"The tubal fimbria is a preferred site for early adenocarcinoma in women with familial ovarian cancer syndrome","volume":"30","author":"Medeiros","year":"2006","journal-title":"Am J Surg Pathol"},{"key":"R83-20230824","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1038\/modpathol.2014.76","article-title":"Primary sources of pelvic serous cancer in patients with endometrial intraepithelial carcinoma","volume":"28","author":"Jia","year":"2015","journal-title":"Mod Pathol"},{"key":"R84-20230824","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1097\/PGP.0000000000000109","article-title":"Characterization of precursor lesions in the endometrium and fallopian tube epithelium of early-stage uterine serous carcinoma","volume":"34","author":"Tolcher","year":"2015","journal-title":"Int J Gynecol Pathol"},{"key":"R85-20230824","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1038\/modpathol.2013.212","article-title":"M\u00fcllerian precursor lesions in serous ovarian cancer patients: using the SEE-Fim and SEE-End protocol","volume":"27","author":"Mingels","year":"2014","journal-title":"Mod Pathol"},{"key":"R86-20230824","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1097\/PGP.0b013e31826a6446","article-title":"Clinically occult tubal and ovarian high-grade serous carcinomas presenting in uterine samples: diagnostic pitfalls and clues to improve recognition of tumor origin","volume":"32","author":"Bagby","year":"2013","journal-title":"Int J Gynecol Pathol"},{"key":"R87-20230824","doi-asserted-by":"crossref","first-page":"1879","DOI":"10.1016\/j.humpath.2014.05.009","article-title":"The frequency and significance of WT-1 expression in serous endometrial carcinoma","volume":"45","author":"Hedley","year":"2014","journal-title":"Hum Pathol"},{"key":"R88-20230824","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1002\/jso.23993","article-title":"Alteration in PI3K\/mTOR, MAPK pathways and Her2 expression\/ amplification is more frequent in uterine serous carcinoma than ovarian serous carcinoma","volume":"112","author":"Mahdi","year":"2015","journal-title":"J Surg Oncol"},{"key":"R89-20230824","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1038\/modpathol.2008.108","article-title":"Immunophenotyping of serous carcinoma of the female genital tract","volume":"21","author":"Nofech-Mozes","year":"2008","journal-title":"Mod Pathol"},{"key":"R90-20230824","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1016\/j.ygyno.2009.11.012","article-title":"Molecular alterations in uterine serous carcinoma","volume":"116","author":"Hayes","year":"2010","journal-title":"Gynecol Oncol"},{"key":"R91-20230824","doi-asserted-by":"crossref","first-page":"343","DOI":"10.5858\/arpa.2012-0416-RA","article-title":"HER2\/neu in endometrial cancer. A promising therapeutic target with diagnostic challenges","volume":"138","author":"Buza","year":"2014","journal-title":"Arch Pathol Lab Med"},{"key":"R92-20230824","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1097\/PAP.0b013e318234ab18","article-title":"Endometrial carcinomas: a review emphasizing overlapping and distinctive morphological and immunohistochemical features","volume":"18","author":"Bartosch","year":"2011","journal-title":"Adv Anat Pathol"},{"key":"R93-20230824","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/S1092-9134(02)91216-5","article-title":"Invasive micropapillary carcinoma of the breast metastatic to the urinary bladder and endometrium: diagnostic pitfalls and review of the literature of tumors with micropapillary features","volume":"7","author":"Ramalingam","year":"2003","journal-title":"Ann Diagn Pathol"},{"key":"R94-20230824","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1053\/j.semdp.2010.07.001","article-title":"Miscellaneous disorders involving the endometrium","volume":"27","author":"McCluggage","year":"2010","journal-title":"Semin Diagn Pathol"}],"container-title":["International Journal of Gynecological Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/00004347-201901001-00007","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,23]],"date-time":"2023-08-23T21:39:25Z","timestamp":1692826765000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00004347-201901001-00007"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,1]]},"references-count":94,"journal-issue":{"issue":"Supplement 1","published-print":{"date-parts":[[2019]]}},"URL":"https:\/\/doi.org\/10.1097\/pgp.0000000000000553","relation":{},"ISSN":["0277-1691"],"issn-type":[{"value":"0277-1691","type":"print"}],"subject":[],"published":{"date-parts":[[2019,1]]}}}